{"id": "article-22307_0", "title": "Physiology, Gluconeogenesis -- Introduction", "content": "The brain, eye, and kidney are some of the organs\u00a0that have glucose as the\u00a0sole metabolic fuel source. Prolonged fasting or vigorous exercise depletes glycogen stores, making the body switch to de-novo glucose synthesis to\u00a0maintain blood levels of this monosaccharide.\u00a0Gluconeogenesis is the\u00a0process\u00a0that allows the body to\u00a0form glucose from non-hexose precursors, particularly glycerol, lactate, pyruvate, propionate, and glucogenic amino acids. [1]", "contents": "Physiology, Gluconeogenesis -- Introduction. The brain, eye, and kidney are some of the organs\u00a0that have glucose as the\u00a0sole metabolic fuel source. Prolonged fasting or vigorous exercise depletes glycogen stores, making the body switch to de-novo glucose synthesis to\u00a0maintain blood levels of this monosaccharide.\u00a0Gluconeogenesis is the\u00a0process\u00a0that allows the body to\u00a0form glucose from non-hexose precursors, particularly glycerol, lactate, pyruvate, propionate, and glucogenic amino acids. [1]"}
{"id": "article-22307_1", "title": "Physiology, Gluconeogenesis -- Introduction", "content": "Gluconeogenesis essentially reverses\u00a0glycolysis (see Image . Gluconeogenesis). Four enzymes facilitate glucose synthesis by this pathway by\u00a0reversing 3\u00a0highly exergonic glycolytic steps, namely, pyruvate carboxylase, phosphoenol pyruvate carboxykinase (PEPCK),\u00a0fructose-1,6-bisphosphatase, and glucose-6-phosphatase. However, these enzymes are not present in all cell types. Therefore, gluconeogenesis can only occur in specific tissues.\u00a0In humans, gluconeogenesis takes place primarily in the liver and, to a lesser extent, the renal cortex. [2] This article discusses gluconeogenesis and its clinical correlates.", "contents": "Physiology, Gluconeogenesis -- Introduction. Gluconeogenesis essentially reverses\u00a0glycolysis (see Image . Gluconeogenesis). Four enzymes facilitate glucose synthesis by this pathway by\u00a0reversing 3\u00a0highly exergonic glycolytic steps, namely, pyruvate carboxylase, phosphoenol pyruvate carboxykinase (PEPCK),\u00a0fructose-1,6-bisphosphatase, and glucose-6-phosphatase. However, these enzymes are not present in all cell types. Therefore, gluconeogenesis can only occur in specific tissues.\u00a0In humans, gluconeogenesis takes place primarily in the liver and, to a lesser extent, the renal cortex. [2] This article discusses gluconeogenesis and its clinical correlates."}
{"id": "article-22307_2", "title": "Physiology, Gluconeogenesis -- Issues of Concern", "content": "Only a moderate amount of glucose can be synthesized by gluconeogenesis, but failure of this pathway is typically fatal.\u00a0Acute hypoglycemia can damage the brain and kidneys because of their dependence on glucose for fuel. Gluconeogenesis is also one of the body's main clearing mechanisms for the muscle and erythrocyte metabolite, lactic acid. Lactic acidosis arising from shock is associated with increased mortality risk. [14]", "contents": "Physiology, Gluconeogenesis -- Issues of Concern. Only a moderate amount of glucose can be synthesized by gluconeogenesis, but failure of this pathway is typically fatal.\u00a0Acute hypoglycemia can damage the brain and kidneys because of their dependence on glucose for fuel. Gluconeogenesis is also one of the body's main clearing mechanisms for the muscle and erythrocyte metabolite, lactic acid. Lactic acidosis arising from shock is associated with increased mortality risk. [14]"}
{"id": "article-22307_3", "title": "Physiology, Gluconeogenesis -- Cellular Level -- Gluconeogenesis Reactions And Enzymes", "content": "The primary stimulus for gluconeogenesis is low blood glucose. Starting\u00a0with pyruvate, the reactions\u00a0involved in gluconeogenesis are the following:", "contents": "Physiology, Gluconeogenesis -- Cellular Level -- Gluconeogenesis Reactions And Enzymes. The primary stimulus for gluconeogenesis is low blood glucose. Starting\u00a0with pyruvate, the reactions\u00a0involved in gluconeogenesis are the following:"}
{"id": "article-22307_4", "title": "Physiology, Gluconeogenesis -- Cellular Level -- Gluconeogenesis Reactions And Enzymes", "content": "In the mitochondrion, pyruvate carboxylase\u00a0converts pyruvate to oxaloacetate. Pyruvate carboxylase requires ATP and the coenzyme biotin for activation. This conversion is the first\u00a0step that reverses the nonequilibrium reaction catalyzed by the glycolytic enzyme\u00a0pyruvate kinase.", "contents": "Physiology, Gluconeogenesis -- Cellular Level -- Gluconeogenesis Reactions And Enzymes. In the mitochondrion, pyruvate carboxylase\u00a0converts pyruvate to oxaloacetate. Pyruvate carboxylase requires ATP and the coenzyme biotin for activation. This conversion is the first\u00a0step that reverses the nonequilibrium reaction catalyzed by the glycolytic enzyme\u00a0pyruvate kinase."}
{"id": "article-22307_5", "title": "Physiology, Gluconeogenesis -- Cellular Level -- Gluconeogenesis Reactions And Enzymes", "content": "Oxaloacetate is converted to malate before it crosses the mitochondrial membrane. Malate is converted back to oxaloacetate once in the cytosol.", "contents": "Physiology, Gluconeogenesis -- Cellular Level -- Gluconeogenesis Reactions And Enzymes. Oxaloacetate is converted to malate before it crosses the mitochondrial membrane. Malate is converted back to oxaloacetate once in the cytosol."}
{"id": "article-22307_6", "title": "Physiology, Gluconeogenesis -- Cellular Level -- Gluconeogenesis Reactions And Enzymes", "content": "In the cytosol,\u00a0PEPCK decarboxylates oxaloacetate, which then rearranges to form phosphoenol pyruvate (PEP).\u00a0PEPCK requires GTP and magnesium ions for activation. This\u00a0transformation is the second\u00a0step that reverses the nonequilibrium reaction catalyzed by pyruvate kinase.", "contents": "Physiology, Gluconeogenesis -- Cellular Level -- Gluconeogenesis Reactions And Enzymes. In the cytosol,\u00a0PEPCK decarboxylates oxaloacetate, which then rearranges to form phosphoenol pyruvate (PEP).\u00a0PEPCK requires GTP and magnesium ions for activation. This\u00a0transformation is the second\u00a0step that reverses the nonequilibrium reaction catalyzed by pyruvate kinase."}
{"id": "article-22307_7", "title": "Physiology, Gluconeogenesis -- Cellular Level -- Gluconeogenesis Reactions And Enzymes", "content": "Enolase hydrates PEP to form 2-phosphoglycerate.", "contents": "Physiology, Gluconeogenesis -- Cellular Level -- Gluconeogenesis Reactions And Enzymes. Enolase hydrates PEP to form 2-phosphoglycerate."}
{"id": "article-22307_8", "title": "Physiology, Gluconeogenesis -- Cellular Level -- Gluconeogenesis Reactions And Enzymes", "content": "Phosphoglycerate mutase converts 2-phosphoglycerate to 3-phosphoglycerate.", "contents": "Physiology, Gluconeogenesis -- Cellular Level -- Gluconeogenesis Reactions And Enzymes. Phosphoglycerate mutase converts 2-phosphoglycerate to 3-phosphoglycerate."}
{"id": "article-22307_9", "title": "Physiology, Gluconeogenesis -- Cellular Level -- Gluconeogenesis Reactions And Enzymes", "content": "Phosphoglycerate kinase phosphorylates 3-phosphoglycerate to form 1,3-bisphosphoglycerate. This reaction requires ATP.", "contents": "Physiology, Gluconeogenesis -- Cellular Level -- Gluconeogenesis Reactions And Enzymes. Phosphoglycerate kinase phosphorylates 3-phosphoglycerate to form 1,3-bisphosphoglycerate. This reaction requires ATP."}
{"id": "article-22307_10", "title": "Physiology, Gluconeogenesis -- Cellular Level -- Gluconeogenesis Reactions And Enzymes", "content": "Glyceraldehyde-3-phosphate dehydrogenase reduces 1,3-bisphosphoglycerate to glyceraldehyde 3-phosphate. Reduced nicotinamide adenine dinucleotide (NADH) is the electron donor.", "contents": "Physiology, Gluconeogenesis -- Cellular Level -- Gluconeogenesis Reactions And Enzymes. Glyceraldehyde-3-phosphate dehydrogenase reduces 1,3-bisphosphoglycerate to glyceraldehyde 3-phosphate. Reduced nicotinamide adenine dinucleotide (NADH) is the electron donor."}
{"id": "article-22307_11", "title": "Physiology, Gluconeogenesis -- Cellular Level -- Gluconeogenesis Reactions And Enzymes", "content": "Triose phosphate isomerase isomerizes glyceraldehyde 3-phosphate to form dihydroxyacetone phosphate (DHAP).", "contents": "Physiology, Gluconeogenesis -- Cellular Level -- Gluconeogenesis Reactions And Enzymes. Triose phosphate isomerase isomerizes glyceraldehyde 3-phosphate to form dihydroxyacetone phosphate (DHAP)."}
{"id": "article-22307_12", "title": "Physiology, Gluconeogenesis -- Cellular Level -- Gluconeogenesis Reactions And Enzymes", "content": "Aldolase combines glyceraldehyde 3-phosphate and\u00a0DHAP to form fructose 1,6-bisphosphate.", "contents": "Physiology, Gluconeogenesis -- Cellular Level -- Gluconeogenesis Reactions And Enzymes. Aldolase combines glyceraldehyde 3-phosphate and\u00a0DHAP to form fructose 1,6-bisphosphate."}
{"id": "article-22307_13", "title": "Physiology, Gluconeogenesis -- Cellular Level -- Gluconeogenesis Reactions And Enzymes", "content": "Fructose-1,6-bisphosphatase dephosphorylates fructose 1,6-bisphosphate to form\u00a0fructose 6-phosphate. This step reverses the\u00a0nonequilibrium reaction catalyzed by the glycolytic enzyme phosphofructokinase-1.", "contents": "Physiology, Gluconeogenesis -- Cellular Level -- Gluconeogenesis Reactions And Enzymes. Fructose-1,6-bisphosphatase dephosphorylates fructose 1,6-bisphosphate to form\u00a0fructose 6-phosphate. This step reverses the\u00a0nonequilibrium reaction catalyzed by the glycolytic enzyme phosphofructokinase-1."}
{"id": "article-22307_14", "title": "Physiology, Gluconeogenesis -- Cellular Level -- Gluconeogenesis Reactions And Enzymes", "content": "Phosphohexose isomerase converts fructose 6-phosphate to glucose 6-phosphate.", "contents": "Physiology, Gluconeogenesis -- Cellular Level -- Gluconeogenesis Reactions And Enzymes. Phosphohexose isomerase converts fructose 6-phosphate to glucose 6-phosphate."}
{"id": "article-22307_15", "title": "Physiology, Gluconeogenesis -- Cellular Level -- Gluconeogenesis Reactions And Enzymes", "content": "Glucose-6-phosphatase dephosphorylates glucose 6-phosphate to form glucose, which\u00a0can enter the bloodstream freely.\u00a0This\u00a0last reaction\u00a0reverses the nonequilibrium reaction catalyzed by the glycolytic enzyme hexokinase.", "contents": "Physiology, Gluconeogenesis -- Cellular Level -- Gluconeogenesis Reactions And Enzymes. Glucose-6-phosphatase dephosphorylates glucose 6-phosphate to form glucose, which\u00a0can enter the bloodstream freely.\u00a0This\u00a0last reaction\u00a0reverses the nonequilibrium reaction catalyzed by the glycolytic enzyme hexokinase."}
{"id": "article-22307_16", "title": "Physiology, Gluconeogenesis -- Cellular Level -- Substrates Of Gluconeogenesis", "content": "The major substrates of gluconeogenesis are lactate, glycerol, and glucogenic amino acids.", "contents": "Physiology, Gluconeogenesis -- Cellular Level -- Substrates Of Gluconeogenesis. The major substrates of gluconeogenesis are lactate, glycerol, and glucogenic amino acids."}
{"id": "article-22307_17", "title": "Physiology, Gluconeogenesis -- Cellular Level -- Substrates Of Gluconeogenesis", "content": "Lactate is\u00a0a product of anaerobic glycolysis.\u00a0This ATP-generating process occurs when\u00a0oxygen is limited, eg, during vigorous exercise or low-perfusion states. Cells that use this pathway, such as the erythrocytes, lack mitochondria\u00a0and\u00a0are not equipped for oxidative phosphorylation. The liver\u00a0uses lactate in the blood to produce glucose via gluconeogenesis. Glucose gets released into the bloodstream, travels back to the erythrocytes and exercising muscles,\u00a0and is metabolized back into\u00a0lactate. This process is\u00a0called the Cori cycle. [2]", "contents": "Physiology, Gluconeogenesis -- Cellular Level -- Substrates Of Gluconeogenesis. Lactate is\u00a0a product of anaerobic glycolysis.\u00a0This ATP-generating process occurs when\u00a0oxygen is limited, eg, during vigorous exercise or low-perfusion states. Cells that use this pathway, such as the erythrocytes, lack mitochondria\u00a0and\u00a0are not equipped for oxidative phosphorylation. The liver\u00a0uses lactate in the blood to produce glucose via gluconeogenesis. Glucose gets released into the bloodstream, travels back to the erythrocytes and exercising muscles,\u00a0and is metabolized back into\u00a0lactate. This process is\u00a0called the Cori cycle. [2]"}
{"id": "article-22307_18", "title": "Physiology, Gluconeogenesis -- Cellular Level -- Substrates Of Gluconeogenesis", "content": "Glycerol comes from adipose tissue lipolysis. This process breaks down triglycerides to form\u00a0fatty acids and glycerol molecules. In the liver, glycerol kinase phosphorylates glycerol to form\u00a0glycerol phosphate. Glycerol phosphate dehydrogenase\u00a0oxidizes glycerol phosphate\u00a0into the glycolytic intermediate,\u00a0DHAP. [3]", "contents": "Physiology, Gluconeogenesis -- Cellular Level -- Substrates Of Gluconeogenesis. Glycerol comes from adipose tissue lipolysis. This process breaks down triglycerides to form\u00a0fatty acids and glycerol molecules. In the liver, glycerol kinase phosphorylates glycerol to form\u00a0glycerol phosphate. Glycerol phosphate dehydrogenase\u00a0oxidizes glycerol phosphate\u00a0into the glycolytic intermediate,\u00a0DHAP. [3]"}
{"id": "article-22307_19", "title": "Physiology, Gluconeogenesis -- Cellular Level -- Substrates Of Gluconeogenesis", "content": "Glucogenic amino acids enter the gluconeogenesis pathway via the citric acid cycle (see Image . Glucogenic Amino Acids). The first step is the deamination of the glucogenic amino acids into \u03b1-ketoacids, which are substrates in the citric acid cycle. From there, these \u03b1-ketoacids are converted to\u00a0oxaloacetate, the substrate for PEPCK.", "contents": "Physiology, Gluconeogenesis -- Cellular Level -- Substrates Of Gluconeogenesis. Glucogenic amino acids enter the gluconeogenesis pathway via the citric acid cycle (see Image . Glucogenic Amino Acids). The first step is the deamination of the glucogenic amino acids into \u03b1-ketoacids, which are substrates in the citric acid cycle. From there, these \u03b1-ketoacids are converted to\u00a0oxaloacetate, the substrate for PEPCK."}
{"id": "article-22307_20", "title": "Physiology, Gluconeogenesis -- Cellular Level -- Regulation Of Gluconeogenesis", "content": "Gluconeogenesis reactions are highly endergonic and, thus, easily reversible. Controls at various levels ensure that each reaction moves forward until free glucose is produced.\u00a0Glucagon is the most important promoter of gluconeogenesis. Secondary ones include the catecholamines, growth hormone, cortisol, and gluconeogenic substrates. [4] [5]", "contents": "Physiology, Gluconeogenesis -- Cellular Level -- Regulation Of Gluconeogenesis. Gluconeogenesis reactions are highly endergonic and, thus, easily reversible. Controls at various levels ensure that each reaction moves forward until free glucose is produced.\u00a0Glucagon is the most important promoter of gluconeogenesis. Secondary ones include the catecholamines, growth hormone, cortisol, and gluconeogenic substrates. [4] [5]"}
{"id": "article-22307_21", "title": "Physiology, Gluconeogenesis -- Cellular Level -- Regulation Of Gluconeogenesis", "content": "The pancreatic alpha cells secrete glucagon in response to falling blood glucose levels. This hormone increases the concentration of cyclic adenosine monophosphate (cAMP), which inactivates glycolytic enzymes\u00a0while activating gluconeogenic ones. Catecholamines produce the same effect by enhancing intracellular cAMP concentration. [6] [7] Insulin is a potent inhibitor of gluconeogenesis. [8] Falling insulin levels during fasting activate\u00a0gluconeogenesis and the processes that increase the availability of gluconeogenic substrates. [4]", "contents": "Physiology, Gluconeogenesis -- Cellular Level -- Regulation Of Gluconeogenesis. The pancreatic alpha cells secrete glucagon in response to falling blood glucose levels. This hormone increases the concentration of cyclic adenosine monophosphate (cAMP), which inactivates glycolytic enzymes\u00a0while activating gluconeogenic ones. Catecholamines produce the same effect by enhancing intracellular cAMP concentration. [6] [7] Insulin is a potent inhibitor of gluconeogenesis. [8] Falling insulin levels during fasting activate\u00a0gluconeogenesis and the processes that increase the availability of gluconeogenic substrates. [4]"}
{"id": "article-22307_22", "title": "Physiology, Gluconeogenesis -- Cellular Level -- Regulation Of Gluconeogenesis", "content": "The alanine cycle,\u00a0aka the Cahill cycle, augments gluconeogenic glucose production during fasting.\u00a0In skeletal muscle, alanine aminotransferase (ALT) transfers an \u03b1-amino group from glutamate to pyruvate, producing alanine and \u03b1-ketoglutarate. Alanine is released from skeletal muscle and taken up by the liver for transamination back to pyruvate. Pyruvate can then be used for gluconeogenesis. [9] [10]", "contents": "Physiology, Gluconeogenesis -- Cellular Level -- Regulation Of Gluconeogenesis. The alanine cycle,\u00a0aka the Cahill cycle, augments gluconeogenic glucose production during fasting.\u00a0In skeletal muscle, alanine aminotransferase (ALT) transfers an \u03b1-amino group from glutamate to pyruvate, producing alanine and \u03b1-ketoglutarate. Alanine is released from skeletal muscle and taken up by the liver for transamination back to pyruvate. Pyruvate can then be used for gluconeogenesis. [9] [10]"}
{"id": "article-22307_23", "title": "Physiology, Gluconeogenesis -- Organ Systems Involved", "content": "During the first 18 to 24 hours of fasting, gluconeogenesis mostly occurs in the liver. Prolonged starvation forces the kidneys to assume as much as 20% of the total\u00a0glucose production by this pathway.\u00a0Only the liver and kidneys have the\u00a0gluconeogenic enzyme glucose-6-phosphatase and, thus, have the ability to convert\u00a0glucose 6-phosphate\u00a0into free glucose. [1] [2]", "contents": "Physiology, Gluconeogenesis -- Organ Systems Involved. During the first 18 to 24 hours of fasting, gluconeogenesis mostly occurs in the liver. Prolonged starvation forces the kidneys to assume as much as 20% of the total\u00a0glucose production by this pathway.\u00a0Only the liver and kidneys have the\u00a0gluconeogenic enzyme glucose-6-phosphatase and, thus, have the ability to convert\u00a0glucose 6-phosphate\u00a0into free glucose. [1] [2]"}
{"id": "article-22307_24", "title": "Physiology, Gluconeogenesis -- Function", "content": "Gluconeogenesis maintains blood glucose levels during starvation. Some tissues in the human body rely almost exclusively on glucose as a metabolic fuel source. The brain, for example, requires approximately 120 g of glucose per day. Ketone bodies can serve as the brain's alternative fuel source. However, the testes, renal medulla, and erythrocytes cannot survive long periods without glucose.\u00a0Gluconeogenesis starts 4 to 6 hours after fasting begins, peaking after 24\u00a0when\u00a0hepatic glycogen is depleted. [1] [2] [15]", "contents": "Physiology, Gluconeogenesis -- Function. Gluconeogenesis maintains blood glucose levels during starvation. Some tissues in the human body rely almost exclusively on glucose as a metabolic fuel source. The brain, for example, requires approximately 120 g of glucose per day. Ketone bodies can serve as the brain's alternative fuel source. However, the testes, renal medulla, and erythrocytes cannot survive long periods without glucose.\u00a0Gluconeogenesis starts 4 to 6 hours after fasting begins, peaking after 24\u00a0when\u00a0hepatic glycogen is depleted. [1] [2] [15]"}
{"id": "article-22307_25", "title": "Physiology, Gluconeogenesis -- Pathophysiology", "content": "Von Gierke disease is an autosomal recessive condition notable for deficiency of the key gluconeogenic enzyme glucose-6-phosphatase. Gluconeogenesis is impaired, resulting in\u00a0fasting hypoglycemia. Glycogenolysis is also affected, as free glucose in the last step of this pathway needs the same enzyme for conversion\u00a0from\u00a0glucose 6-phosphate.\u00a0Other metabolic\u00a0abnormalities\u00a0that can manifest in von Gierke disease are hyperkalemia, hyperuricemia, and lactic acidosis. [11]", "contents": "Physiology, Gluconeogenesis -- Pathophysiology. Von Gierke disease is an autosomal recessive condition notable for deficiency of the key gluconeogenic enzyme glucose-6-phosphatase. Gluconeogenesis is impaired, resulting in\u00a0fasting hypoglycemia. Glycogenolysis is also affected, as free glucose in the last step of this pathway needs the same enzyme for conversion\u00a0from\u00a0glucose 6-phosphate.\u00a0Other metabolic\u00a0abnormalities\u00a0that can manifest in von Gierke disease are hyperkalemia, hyperuricemia, and lactic acidosis. [11]"}
{"id": "article-22307_26", "title": "Physiology, Gluconeogenesis -- Clinical Significance -- Treating Hyperglycemia in Diabetes", "content": "Diabetes\u00a0may result\u00a0from impaired insulin production or decreased insulin sensitivity. Besides\u00a0stimulating glucose uptake from the bloodstream, insulin is also a potent gluconeogenesis inhibitor. Gluconeogenesis occurs at\u00a0an unusually rapid rate in insulin deficiency or insensitivity, increasing the risk of hyperglycemia in patients with diabetes mellitus. [1]", "contents": "Physiology, Gluconeogenesis -- Clinical Significance -- Treating Hyperglycemia in Diabetes. Diabetes\u00a0may result\u00a0from impaired insulin production or decreased insulin sensitivity. Besides\u00a0stimulating glucose uptake from the bloodstream, insulin is also a potent gluconeogenesis inhibitor. Gluconeogenesis occurs at\u00a0an unusually rapid rate in insulin deficiency or insensitivity, increasing the risk of hyperglycemia in patients with diabetes mellitus. [1]"}
{"id": "article-22307_27", "title": "Physiology, Gluconeogenesis -- Clinical Significance -- Treating Hyperglycemia in Diabetes", "content": "Metformin, the first-line agent for\u00a0type 2 diabetes mellitus management, has been shown to suppress hepatic gluconeogenesis\u00a0by various mechanisms.\u00a0This drug\u00a0activates adenosine monophosphate-activated protein kinase (AMPK), which, in turn, inhibits hepatic lipogenesis and increases insulin sensitivity.\u00a0AMPK activation also increases cAMP breakdown, further\u00a0suppressing gluconeogenesis. [1] [12]", "contents": "Physiology, Gluconeogenesis -- Clinical Significance -- Treating Hyperglycemia in Diabetes. Metformin, the first-line agent for\u00a0type 2 diabetes mellitus management, has been shown to suppress hepatic gluconeogenesis\u00a0by various mechanisms.\u00a0This drug\u00a0activates adenosine monophosphate-activated protein kinase (AMPK), which, in turn, inhibits hepatic lipogenesis and increases insulin sensitivity.\u00a0AMPK activation also increases cAMP breakdown, further\u00a0suppressing gluconeogenesis. [1] [12]"}
{"id": "article-22307_28", "title": "Physiology, Gluconeogenesis -- Clinical Significance -- Treating Hyperglycemia in Diabetes", "content": "Metformin also appears to directly inhibit glycerol-3-phosphate dehydrogenase, increasing\u00a0NADH levels. [1] [12] High intracellular NADH favors the formation of lactate over pyruvate by the\u00a0lactate dehydrogenase\u00a0reaction. Gluconeogenesis using lactate as a substrate cannot proceed without this molecule's conversion back to pyruvate. At high doses, metformin also inhibits complex I of the electron transport chain, the ATP production that drives highly endergonic processes like\u00a0gluconeogenesis. [1]", "contents": "Physiology, Gluconeogenesis -- Clinical Significance -- Treating Hyperglycemia in Diabetes. Metformin also appears to directly inhibit glycerol-3-phosphate dehydrogenase, increasing\u00a0NADH levels. [1] [12] High intracellular NADH favors the formation of lactate over pyruvate by the\u00a0lactate dehydrogenase\u00a0reaction. Gluconeogenesis using lactate as a substrate cannot proceed without this molecule's conversion back to pyruvate. At high doses, metformin also inhibits complex I of the electron transport chain, the ATP production that drives highly endergonic processes like\u00a0gluconeogenesis. [1]"}
{"id": "article-22307_29", "title": "Physiology, Gluconeogenesis -- Clinical Significance -- Hypoglycemia as a Result of Ethanol Consumption", "content": "Ethanol clearance from the body begins with its oxidation into\u00a0acetaldehyde by hepatic\u00a0alcohol dehydrogenase. This enzyme uses oxidized nicotinamide adenine dinucleotide (NAD+) as an electron acceptor. Aldehyde dehydrogenase oxidizes\u00a0acetaldehyde further into acetate, which is readily excreted by the body.\u00a0Aldehyde dehydrogenase also requires NAD+ as a cofactor.\u00a0Thus,\u00a0ethanol\u00a0metabolism results in NADH accumulation. [13]", "contents": "Physiology, Gluconeogenesis -- Clinical Significance -- Hypoglycemia as a Result of Ethanol Consumption. Ethanol clearance from the body begins with its oxidation into\u00a0acetaldehyde by hepatic\u00a0alcohol dehydrogenase. This enzyme uses oxidized nicotinamide adenine dinucleotide (NAD+) as an electron acceptor. Aldehyde dehydrogenase oxidizes\u00a0acetaldehyde further into acetate, which is readily excreted by the body.\u00a0Aldehyde dehydrogenase also requires NAD+ as a cofactor.\u00a0Thus,\u00a0ethanol\u00a0metabolism results in NADH accumulation. [13]"}
{"id": "article-22307_30", "title": "Physiology, Gluconeogenesis -- Clinical Significance -- Hypoglycemia as a Result of Ethanol Consumption", "content": "As previously mentioned, high intracellular NADH\u00a0increases\u00a0lactic acid formation, which can inhibit gluconeogenesis. Thus, heavy ethanol consumption\u00a0can lead to both lactic acidosis and hypoglycemia. [13]", "contents": "Physiology, Gluconeogenesis -- Clinical Significance -- Hypoglycemia as a Result of Ethanol Consumption. As previously mentioned, high intracellular NADH\u00a0increases\u00a0lactic acid formation, which can inhibit gluconeogenesis. Thus, heavy ethanol consumption\u00a0can lead to both lactic acidosis and hypoglycemia. [13]"}
{"id": "article-22307_31", "title": "Physiology, Gluconeogenesis -- Clinical Significance -- Hypoglycemia in the Preterm Infant", "content": "Preterm infants are particularly\u00a0at risk of developing hypoglycemia. Low-birth-weight neonates have limited glycogen and fat stores but also express gluconeogenic enzymes at suboptimal levels. Preterm infants' energy stores can diminish quickly,\u00a0as they cannot mount\u00a0an adequate\u00a0counterregulatory response. [4]", "contents": "Physiology, Gluconeogenesis -- Clinical Significance -- Hypoglycemia in the Preterm Infant. Preterm infants are particularly\u00a0at risk of developing hypoglycemia. Low-birth-weight neonates have limited glycogen and fat stores but also express gluconeogenic enzymes at suboptimal levels. Preterm infants' energy stores can diminish quickly,\u00a0as they cannot mount\u00a0an adequate\u00a0counterregulatory response. [4]"}
{"id": "article-22307_32", "title": "Physiology, Gluconeogenesis -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Physiology, Gluconeogenesis -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}